AbCellera, tapped by Lilly for its COVID-19 antibody therapy, sets IPO terms with $5B valuation

AbCellera, tapped by Lilly for its COVID-19 antibody therapy, sets IPO terms with $5B valuation
badams
Mon, 12/07/2020 – 09:43

Published on Mon, 07 Dec 2020 14:43:49 +0000 with keywords power automate remove from collection